Remoxipride
Back to searchMolecule Structure
Scientific Name
Remoxipride
Description of the Drug
Remoxipride is an discontinued atypical antipsychotic selective for dopamine D2 receptors.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00409
http://www.drugbank.ca/drugs/DB00409
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL121339 | |
| PharmGKB | PA164749051 | |
| Human Metabolome Database | HMDB0014553 | |
| DrugBank | DB00409 | |
| PubChem: Thomson Pharma | 14755372 | |
| PubChem | 54477 | |
| LINCS | LSM-3202 | |
| Nikkaji | J138.394I | |
| BindingDB | 50026045 | |
| EPA CompTox Dashboard | DTXSID6045668 | |
| DrugCentral | 2365 | |
| Brenda | 147734 | |
| ChemicalBook | CB2493967 | |
| rxnorm | REMOXIPRIDE HYDROCHLORIDE | REMOXIPRIDE |
| PubChem: Drugs of the Future | 12012970 | |
| ChEBI | 92948 | |
| ZINC | ZINC000002021799 |
